AbbVie
ABBV
#30
Rank
NZ$793.49 B
Marketcap
NZ$449.11
Share price
4.20%
Change (1 day)
50.53%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of March 2026 : -NZ$11.73 Billion

According to AbbVie's latest financial reports the company has -NZ$11.73 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-NZ$5.58 Billion-193.44%
2024-12-31$NZ$5.96 B-63.72%
2023-12-31$NZ$16.44 B-39.62%
2022-12-31$NZ$27.22 B20.48%
2021-12-31$NZ$22.59 B24.5%
2020-12-31$NZ$18.15 B-249.59%
2019-12-31$-NZ$12.14 Billion-3.63%
2018-12-31$-NZ$12.6 Billion-275.45%
2017-12-31$NZ$7.17 B7.23%
2016-12-31$NZ$6.69 B16.11%
2015-12-31$NZ$5.76 B159.25%
2014-12-31$NZ$2.22 B-59.33%
2013-12-31$NZ$5.46 B33.71%
2012-12-31$NZ$4.08 B-73.26%
2011-12-31$NZ$15.28 B-24.89%
2010-12-31$NZ$20.35 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$160.25 B-1,467.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.30 B-571.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.29 B-238.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$33.06 B-382.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$41.53 B-454.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$35.63 B-404.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$83.99 B-816.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$40.90 B-448.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$6.04 B-151.53%๐Ÿ‡บ๐Ÿ‡ธ USA